Innovation Park Basel Area

Innovation Log

SWITZERLAND INNOVATION PARK BASEL AREA WELCOMES NEW RESIDENTS IN APRIL 2018

The Park Basel Area community is growing – we are delighted to welcome four new startups in April.

With Polyneuron Pharmaceuticals, a spin-off from University of Basel, and the Polish biotech startup Captor Therapeutics, Park Basel Area gains new experts in the field of innovative health-oriented life sciences.

The French biotech startup Algae Natural Switzerland, which aims to contribute to a healthier nutrition with its microalgae, and a recently founded medtech company in stealth mode further expand the startup portfolio.

Algae Natural Switzerland
Algae Natural Switzerland AG provides protein and/or omega-3 rich high-quality microalgae for food and feed applications. The company’s production process for organic microalgae is developed based on a sustainable and circular approach for a successful eco-conception.

Captor Therapeutics
Captor Therapeutics is a Polish biotech company developing drug candidates for the treatment of oncology and chronic inflammation.

Polyneuron Pharmaceuticals
Polyneuron Pharmaceuticals is a spin-off from the University of Basel focusing on the development of a promising new drug class to treat autoimmune disorders.

Medtech company in stealth mode.

Leave a Comment:

«You may also like»

SWITZERLAND INNOVATION PARK BASEL AREA PRESENTS ITS LATEST ARRIVALS

The Park Basel Area community is growing – we are delighted to present our new residents.…> Read more
View of Switzerland Innovation Park Basel Area in Allschwil

Allschwil – Birthplace of ground-breaking life sciences companies

Located in the midst of the Life Sciences Cluster Basel, Allschwil is a great location for…> Read more

Register for the DBE Research Day 2018

On September 5, 2018, the Department of Biomedical Engineering (DBE) is open to the public. Guests,…> Read more